Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 12:12:100346.
doi: 10.1016/j.prdoa.2025.100346. eCollection 2025.

Correlation analyses between MIBG myocardial scintigraphy and monoamine levels in dementia with Lewy bodies show potential link with the serotonergic system

Affiliations

Correlation analyses between MIBG myocardial scintigraphy and monoamine levels in dementia with Lewy bodies show potential link with the serotonergic system

Annelies Heylen et al. Clin Park Relat Disord. .

Abstract

Setting: Dementia with Lewy bodies (DLB) remains poorly understood and frequently misdiagnosed, complicated by co-pathology with other dementia forms. DLB patients often present with autonomic dysfunction and peripheral Lewy body pathology alongside central lesions. Monoaminergic neurotransmitter systems seem an early target for DLB pathology, especially the noradrenergic system. Noradrenaline analogue 123I-metaiodobenzylguanidine (MIBG) is considered an indicative biomarker for peripheral noradrenergic sympathetic denervation.

Objectives: Our aim was to measure paired monoaminergic levels and MIBG scintigraphy values in DLB patients, exploring a possible link between noradrenergic neurotransmission and peripheral denervation.

Design: 44 patients with a possible DLB diagnosis entered the study. Peripheral uptake of 123I-MIBG was determined by the heart-to-mediastinum (H/M) ratio, as a measure for noradrenergic sympathetic denervation. In cerebrospinal fluid (CSF), serum and plasma samples, monoamines ((nor)adrenaline ((N)A), 5-hydroxytryptamin (5-HT, serotonin), dopamine (DA)) and respective metabolites (3-methoxy-4-hydroxyphenylglycol (MHPG), 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA) and 3,4-dihydroxyphenylacetic acid (DOPAC)), were measured by means of reversed-phase ultrahigh-performance liquid chromatography with electrochemical detection.

Results: We found significant correlations between the H/M ratio and serum 5-HIAA, plasma 5-HT, plasma 5-HIAA/5-HT and plasma HVA/5-HIAA, but no further correlations with the noradrenergic system. CSF-serum MHPG, CSF-serum DOPAC, CSF-serum HVA, CSF-plasma MHPG, CSF plasma NA, CSF-plasma DOPAC, CSF-plasma MHPG/NA and CSF-plasma DOPAC/DA were significantly correlated.

Conclusions: These results show an association between the H/M ratio and serotonergic system, but not between peripheral noradrenergic denervation and circulating noradrenergic levels.

Keywords: 5-HIAA; 5-HT; Biogenic amines; DLB; Dopamine; H/M ratio; Noradrenaline; Norepinephrine; Serotonin; UPLC.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Correlations between H/M ratio, blood 5-HIAA, 5-HT levels and 5-HIAA/5-HT and HVA/5-HIAA ratios. Correlation strength is visualized by color shade and correlation coefficients. Significance values are classified as P ≤ 0.05, P ≤ 0.01 and P ≤ 0.001 and are indicated by one, two or three asterisk symbols, respectively. Abbreviations: H/M = heart-to-mediastinum, 5-HIAA = 5-hydroxyindoleacetic acid, DA = dopamine, HVA = homovanillic acid, 5-HT = 5-hydroxytryptamine (serotonin).

Similar articles

References

    1. World Health Organization (2017, December 7). Global action plan on the public health response to dementia 2017 – 2025. https://www.who.int/publications/i/item/global-action-plan-on-the-public....
    1. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. PNAS. 1998;95(11):6469–6473. doi: 10.1073/pnas.95.11.6469. - DOI - PMC - PubMed
    1. Kaufmann H., Nahm K., Purohit D., Wolfe D. Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology. 2004;63(6):1093–1095. doi: 10.1212/01.wnl.0000138500.73671.dc. - DOI - PubMed
    1. McKeith I.G., Ferman T.J., Thomas A.J., Blanc F., Boeve B.F., Fujishiro H., Kantarci K., Muscio C., O'Brien J.T., Postuma R.B., Aarsland D., Ballard C., Bonanni L., Donaghy P., Emre M., Galvin J.E., Galasko D., Goldman J.G., Gomperts S.N., Honig L.S., prodromal DLB Diagnostic Study Group Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020;94(17):743–755. doi: 10.1212/WNL.0000000000009323. - DOI - PMC - PubMed
    1. Yoshita M., Taki J., Yamada M. A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies. J. Neurol. Neurosurg. Psychiatry. 2001;71(5):583–588. doi: 10.1136/jnnp.71.5.583. - DOI - PMC - PubMed

LinkOut - more resources